Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Type-2 cannabinoid receptors in neurodegeneration
Tiziana Bisogno, Sergio Oddi, Alessandra Piccoli, et al.
Pharmacological Research (2016) Vol. 111, pp. 721-730
Closed Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Bioactive lipids, inflammation and chronic diseases
Alessandro Leuti, Domenico Fazio, Marina Fava, et al.
Advanced Drug Delivery Reviews (2020) Vol. 159, pp. 133-169
Closed Access | Times Cited: 244
Targeting Cannabinoid Receptors: Current Status and Prospects of Natural Products
Dongchen An, Steve Peigneur, Louise Antonia Hendrickx, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 14, pp. 5064-5064
Open Access | Times Cited: 165
From combinations to multitarget‐directed ligands: A continuum in Alzheimer's disease polypharmacology
Claudia Albertini, Alessandra Salerno, Pedro de Sena Murteira Pinheiro, et al.
Medicinal Research Reviews (2020) Vol. 41, Iss. 5, pp. 2606-2633
Closed Access | Times Cited: 129
Microglial Activation in the Pathogenesis of Huntington’s Disease
Huiming Yang, Su Yang, Shanshan Huang, et al.
Frontiers in Aging Neuroscience (2017) Vol. 9
Open Access | Times Cited: 123
Endocannabinoid Modulation of Microglial Phenotypes in Neuropathology
Mikiei Tanaka, Scott Sackett, Yumin Zhang
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 118
Imaging Neuroinflammation in Neurodegenerative Disorders
Joseph C. Masdeu, Belén Pascual, Masahiro Fujita
Journal of Nuclear Medicine (2022) Vol. 63, Iss. Supplement 1, pp. 45S-52S
Open Access | Times Cited: 41
New insights into butyrylcholinesterase: Pharmaceutical applications, selective inhibitors and multitarget-directed ligands
Tian‐Yu Sun, Tengfei Zhen, Chrisanta Hamis Harakandi, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116569-116569
Closed Access | Times Cited: 16
Cannabinoids therapeutic use: what is our current understanding following the introduction of THC, THC:CBD oromucosal spray and others?
Mauro Maccarrone, Rafaël Maldonado, Miguel Casas, et al.
Expert Review of Clinical Pharmacology (2017) Vol. 10, Iss. 4, pp. 443-455
Closed Access | Times Cited: 74
Neuroprotection by (endo)Cannabinoids in Glaucoma and Retinal Neurodegenerative Diseases
Cinzia Rapino, Daniel Tortolani, Lucia Scipioni, et al.
Current Neuropharmacology (2017) Vol. 16, Iss. 7, pp. 959-970
Open Access | Times Cited: 69
Cannabinoid receptor-2 attenuates neuroinflammation by promoting autophagy-mediated degradation of the NLRP3 inflammasome post spinal cord injury
Fan Jiang, Mingjie Xia, Yanan Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 34
Beyond Pain Relief: A Review on Cannabidiol Potential in Medical Therapies
Mariana Veiga, João Azevedo‐Silva, João Carlos Fernandes
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 155-155
Open Access | Times Cited: 18
Structure–Activity Relationships and Computational Investigations into the Development of Potent and Balanced Dual-Acting Butyrylcholinesterase Inhibitors and Human Cannabinoid Receptor 2 Ligands with Pro-Cognitive in Vivo Profiles
Dominik Dolles, Matthias Hoffmann, Sandra Gunesch, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 4, pp. 1646-1663
Closed Access | Times Cited: 58
β-Caryophyllene Pretreatment Alleviates Focal Cerebral Ischemia-Reperfusion Injury by Activating PI3K/Akt Signaling Pathway
Qian Zhang, Ruidi An, Xiaocui Tian, et al.
Neurochemical Research (2017) Vol. 42, Iss. 5, pp. 1459-1469
Open Access | Times Cited: 50
Endocannabinoid system and adult neurogenesis: a focused review
Sergio Oddi, Lucia Scipioni, Mauro Maccarrone
Current Opinion in Pharmacology (2019) Vol. 50, pp. 25-32
Closed Access | Times Cited: 49
Dual-Acting Cholinesterase–Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in Vivo
Matthias Scheiner, Dominik Dolles, Sandra Gunesch, et al.
Journal of Medicinal Chemistry (2019) Vol. 62, Iss. 20, pp. 9078-9102
Open Access | Times Cited: 43
Allosteric Cannabinoid Receptor 1 (CB1) Ligands Reduce Ocular Pain and Inflammation
Dinesh Thapa, Elizabeth A. Cairns, Anna-Maria Szczesniak, et al.
Molecules (2020) Vol. 25, Iss. 2, pp. 417-417
Open Access | Times Cited: 40
Cannabinoid type 2 receptor agonist JWH-133, attenuates Okadaic acid induced spatial memory impairment and neurodegeneration in rats
Murat Çakır, Suat Tekin, Züleyha Doğanyiğit, et al.
Life Sciences (2018) Vol. 217, pp. 25-33
Closed Access | Times Cited: 45
Neuroprotective Effects of Celastrol in Neurodegenerative Diseases-Unscramble Its Major Mechanisms of Action and Targets
Dandan Liu, Qian Zhang, Piao Luo, et al.
Aging and Disease (2022) Vol. 13, Iss. 3, pp. 815-815
Open Access | Times Cited: 20
The chronological evolution of fluorescent GPCR probes for bioimaging
Yingxu Wu, Boyu Zhang, Hu Xu, et al.
Coordination Chemistry Reviews (2023) Vol. 480, pp. 215040-215040
Closed Access | Times Cited: 13
The PINK1/Parkin signaling pathway-mediated mitophagy: a forgotten protagonist in myocardial ischemia/reperfusion injury
Xiaopeng Zhao, Zheng Wang, Lijie Wang, et al.
Pharmacological Research (2024) Vol. 209, pp. 107466-107466
Open Access | Times Cited: 4
MicroRNA-139 modulates Alzheimer’s-associated pathogenesis in SAMP8 mice by targeting cannabinoid receptor type 2
Yuan Tang, Jisheng Bao, Jianhua Su, et al.
Genetics and Molecular Research (2017) Vol. 16, Iss. 1
Open Access | Times Cited: 35
Alleviation of Neuropathology by Inhibition of Monoacylglycerol Lipase in APP Transgenic Mice Lacking CB2 Receptors
Jian Zhang, Chu Chen
Molecular Neurobiology (2017) Vol. 55, Iss. 6, pp. 4802-4810
Open Access | Times Cited: 34
Possible therapeutic applications of cannabis in the neuropsychopharmacology field
Javier Fernández‐Ruíz, Ismael Galve‐Roperh, Onintza Sagredo, et al.
European Neuropsychopharmacology (2020) Vol. 36, pp. 217-234
Closed Access | Times Cited: 30
Cannabinoid receptor CB2 ablation protects against TAU induced neurodegeneration
Marcos Galán-Ganga, Carmen Rodríguez‐Cueto, Jesús Merchán‐Rubira, et al.
Acta Neuropathologica Communications (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 27
Cannabinoid pharmacology: Research on medicinal cannabins and its therapeutic application
Vedangi Arvind Kulkarni, Himanshi Pramod Nimje, Pratiksha Purushottam Varhade, et al.
Journal of Pharmaceutical and Biological Sciences (2025) Vol. 12, Iss. 2, pp. 135-143
Closed Access
Page 1 - Next Page

Scroll to top